Medical treatment of rheumatoid arthritis;Internistische therapie der rheumatoiden arthritis

Internist

Volumn 45, Issue 6, 2004, Pages 693-706

  Seidel, W ^a   Pierer, M ^a   Hantzschel H ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Antirheumatic therapy; Chronic polyarthritis; Disease modifying antirheumatic drugs; Extraarticular manifestations; Rheumatoid arthritis

Indexed keywords

ADALIMUMAB; ANALGESIC AGENT; ANTIRHEUMATIC AGENT; AZATHIOPRINE; CHLOROQUINE; CORTICOSTEROID; CYCLOSPORIN A; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; GLUCOCORTICOID; GOLD; HYDROXYCHLOROQUINE; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PENICILLAMINE; RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; SALAZOSULFAPYRIDINE; UNCLASSIFIED DRUG;

ARTHROPATHY; CONSERVATIVE TREATMENT; DIFFERENTIAL DIAGNOSIS; DISABILITY; DISEASE COURSE; HUMAN; JOINT RADIOGRAPHY; PHYSIOTHERAPY; PREVALENCE; PROGNOSIS; REVIEW; RHEUMATOID ARTHRITIS; SEX RATIO; SYNOVITIS; TREATMENT OUTCOME;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; ARTHROGRAPHY; DIAGNOSIS, DIFFERENTIAL; DISEASE PROGRESSION; GUIDELINES; HUMANS; INTERNAL MEDICINE; METHOTREXATE; PATIENT CARE MANAGEMENT; PHYSICIAN'S PRACTICE PATTERNS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 3042697411     PISSN: 00209554     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00108-004-1208-5     Document Type: Review

References (47)

1. Agarwal AK, Kraus DR, Elsenbels CHJ, Stolzer BL, Balk PM, Barkley TA (1989) Anatomical and neurological characteristic of cervical spine involvement in rheumatoid arthritis. J Orthop Rheumatol 2: 77-89
2. American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines (2002) Guidelines for the Management of Rheumatoid Arthritis. 2002 Update. Arthritis Rheum 46: 328-346
3. Arbeitsgemeinschaft Regionaler Kooperativer Rheumazentren in der Deutschen Gesellschaft für Rheumatologie (2002) Informationen zur DMARD-Therapie.http://www.rheumanet.org
4. Arnett FC, Edworthy SM, Bloch DA et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315-324
5. Backhaus M (2002) Der Stellenwert der Arthrosonographie in der Früharthritisdiagnostik. Z Rheumatol 61: 120-129
6. Bacon PA, Raza K, Banks MJ, Townend J, Kitas GD (2002) The role of endothelial cell dysfunction in the cardiovascular mortality of RA. Int Rev Immunol 21: 1-17
7. Bas S, Perneger TV, Seitz M, Tiercy JM, Roux-Lombard P, Guerne PA (2002) Diagnostic tests for rheumatoid arthritis: comparison of anti-cyclic citrullinated peptide antibodies, anti-keratin antibodies and IgM rheumatoid factors. Rheumatology (Oxford) 41: 809-814
8. Bell GR, Stearns KL (1991) Flexion-extension MRI of the upper rheumatoid cervical spine. Orthopedics 14: 969-973
9. Bonfiglio T, Atwater EC (1969) Heart disease in patients with seropositive rheumatoid arthritis; a controlled autopsy study a nd review. Arch Intern Med 124: 714-719
10. Bywaters EGL, Scott JT (1963) The natural history of vascular lesions in rheumatoid arthritis. J Chron Dis 16: 905-914
11. Chan ES, Cronstein BN (2002) Molecular action of methotrexate in inflammatory diseases. Arthritis Res 4: 266-273
12. Choi HK, Hernan MA, Seeger JD, Robins JM, Wolfe F (2002) Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet 359: 1173-1177
13. Conn DL, McDuffle FC, Dyck PJ (1972) Immunopathologic study of sural nerves in rheumatoid arthritis. Arthritis Rheum 15: 135-143
14. Emery Reginster JY, Appelboom T et al. (2001) WHO Collaborating Centre consensus meeting on anti-cytokine therapy in rheumatoid arthritis. Rheumatology (Oxford) 40: 699-702
15. Firestein GS, Zvaifler NJ (1990) How important are T cells in chronic rheumatoid synovitis? Arthritis Rheum 33: 768-773
16. Fujii M, Adachi S, Shimizu T, Hirota S, Sako M, Kono M (1993) Interstitial lung disease in rheumatoid arthritis: assessment with high-resolution computed tomography. J Thorac Imaging 8: 54-62
17. Gay S, Gay RE, Koopman WJ (1993) Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction? Ann Rheum Dis 52 (Suppl): S39-S47
18. Hassan WU, Keaney NP, Holland CD, Kelly CA (1995) High resolution computed tomography of the lung in lifelong non-smoking patients with rheumatoid arthritis. Ann Rheum Dis 54: 308-310
19. Healy LA (1986) Rheumatoid arthritis in the elderly. Clin Rheum Dis 12: 173-179
20. Hülsemann JL, Zeldler H (1995) Undifferentiated arthritis in an early synovitis out-patient clinic. Clin Exp Rheumatol 13: 37-43
21. Kaiser H (2000) Corticoide in der Rheumatherapie gestern - heute - morgen. Z Rheumatol 159: 75-85
22. Kavanaugh A, Keenan GF, deWoody K et al. (2001) Long-term follow-up of patients treated with remicade (Infliximab) in clinical trials. Arthritis Rheum 46: S81
23. Kässer UR, Gromnica-Ihle E, Lemmel EM, Bolten WW (1998) Therapie rheumatischer Erkrankungen während Schwan gerschaft und Stillzeit. Novartis, Nürnberg
24. Keitel W (1993) Verlauf der Rheumatoiden Arthritis bei spätem Krankheitsbeginn. Z Rheumatol S2: 138-141
25. Kremer JM, Genovese M, Cannon GW et al. (2002) Comcomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. A randomised, double-blind, placebo-controlled trial. Ann Intern Med 137: 726-733
26. Manger B (2002) Überarbeitete Empfehlungen der Deutschen Gesellschaft für Rheumatologie zur Therapie mit Tumornekrosefaktor- hemmenden Wirkstoffen bei entzüdlich rheumatischen Erkrankungen (Stand Juli 2002). Z Rheumatol 61: 694-697
27. McGavin DD, Williamson J, Forrester JV et al. (1976) Episcleritis and scleritis. A study of their clinical manifestations and association with rheumatoid arthritis. Br J Ophthalmol 60: 192-226
28. McRorie ER, Jobanputra P, Ruckley CV, Nuki G (1994) Clinical review. Leg ulceration in rheumatoid arthritis. Br J Rheumatol 33: 1078-1084
29. Menninger H (1998) Basistherapeutische Kombinationstherapie bei chronischer Polyarthritis: Ein Überblick. Z Rheumatol 57: 25-30
30. Moreland LW, Cohen SB, Baumgartner SW et al. (2001) Long-term safety and efficacy of etanercept in patients with rheumatoid arthritis. J Rheumatol 28: 1238-1244
31. Myllykangas-Luosujärvi R, Aho K, Kautiainen H, Hakala M (1999) Amyloidosis in a nationwide series of 1666 subjects with rheumatoid arthritis who died during 1989 in Finland. Rheumatology (Oxford) 38: 499-503
32. Nitzsche S, Wagner U, Seidel W, Häntzschel H (1999) Entzündungsmechanismen bei rheumatoider Vaskulitis und Riesenzellarteriitis. Internist 40: 922-929
33. O'Dell JR, Haire CE, Erikson N (1996) Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications. N Engl J Med 334: 1287-1291
34. Pinals RS, Masi AT, Larsen RA, and the Subcommittee for Criteria of Remission in Rheumatoid Arthritis of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee (1981) Preliminary criteria for clinical remission in rheumatoid arthritis. Arthritis Rheum 24: 1308-1315
35. Pincus T, Callahan LF, Sale WG, Brooks AL, Payne LE, Vaughn WK (1984) Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum 27: 864-872
36. Schmidt WA, Backhaus M, Sattler H, Kellner H (2003) Bildgebende Verfahren in der Rheumatologie: Sonographie bei rheumatolder Arthritis. Z Rheumatol 62: 23-33
37. Sorsa T, Konttinen YT, Lindy O, Ritchlin C et al. (1992) Collagenase in synovitis of rheumatoid arthritis. Semin Arthritis Rheum 22: 44-S3
38. Stastny P (1978) Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med 298: 869-871
39. Steiner G, Smolen JS (2002) Neue Autoantikörper in der Diagnostik der rheumatoiden Arthritis. Z Rheumatol 61: 667-673
40. Strand V, Sharp JT (2003) Radiographic data from recent randomized controlled trials in rheumatoid arthritis. What have we learned? Arthritis Rheum 48: 21-34
41. Tugwell P, Pincus T, Yocum D et al. (1995) Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. N Engl J Med 333: 137-141
42. Turesson C, O'Fallon WM, Crowson CS, Gabriel SE, Matteson EL (2002) Occurrence of extraarticular disease manifestations in association with excess mortality in a community based cohort of patients with rheumatoid arthritis. J Rheumatol 29: 62-67
43. Wagner U, Kaltenhäuser S, Sauer H et al. (1997) HLA markers and prediction of clinical course and outcome in rheumatoid arthritis. Arthritis Rheum 40: 341-345
44. Walker WC, Wright V (1968) Pulmonary lesions and rheumatoid arthritis. Medicine 47: 501-520
45. Wendling D, Racadot E, Wijdenes J et al. (1998) A randomized, double-blind, placebo controlled multicenter trial of murine anti-CD4 monoclonal antibody therapy in rheumatoid arthritis. J Rheumatol 25: 1457-1461
46. Zink A, Listing J, Niewerth M, Zeidler H, for the German Collaborative Arthritis Centres (2001) The national database of the German Collaborative Arthritis Centres: II. Treatment of patients with rheumatoid arthritis. Ann Rheum Dis 60: 2007-2013
47. Zink A, Mau W, Schneider M (2001) Epidemiologische und sozialmedizinische Aspekte entzündlich-rheumatischer Erkrankungen. Internist 42: 211-222